Globus Medical Stock Book Value Per Share

GMED Stock  USD 53.64  0.58  1.09%   
Globus Medical fundamentals help investors to digest information that contributes to Globus Medical's financial success or failures. It also enables traders to predict the movement of Globus Stock. The fundamental analysis module provides a way to measure Globus Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Globus Medical stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Globus Book Value Per Share Analysis

Globus Medical's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
 2021 2022 2023 2024 (projected)
Gross Profit718.9M759.1M1.0B533.4M
Total Revenue958.1M1.0B1.6B1.6B

Book Value per Share

 = 

Common Equity

Average Shares

More About Book Value Per Share | All Equity Analysis

Current Globus Medical Book Value Per Share

    
  29.32 X  
Most of Globus Medical's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Globus Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Globus Book Value Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Globus Medical is extremely important. It helps to project a fair market value of Globus Stock properly, considering its historical fundamentals such as Book Value Per Share. Since Globus Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Globus Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Globus Medical's interrelated accounts and indicators.
0.91.00.840.790.670.580.960.591.00.990.980.971.00.110.80.640.970.960.69-0.080.91-0.480.120.990.840.88
0.90.880.670.60.880.270.910.350.920.870.950.960.9-0.310.70.360.960.950.41-0.20.71-0.5-0.250.920.760.87
1.00.880.860.810.630.630.960.620.990.990.960.961.00.150.810.690.950.940.73-0.030.93-0.470.180.970.840.86
0.840.670.860.90.420.710.790.660.810.830.770.770.860.310.710.730.740.690.790.250.94-0.630.440.810.760.67
0.790.60.810.90.310.780.750.630.770.790.710.70.80.320.780.850.670.630.910.180.91-0.50.50.760.890.74
0.670.880.630.420.31-0.030.680.020.70.610.760.780.66-0.490.480.050.790.80.11-0.240.4-0.53-0.490.720.560.73
0.580.270.630.710.78-0.030.610.660.550.650.410.390.60.550.70.970.370.330.950.580.79-0.260.780.460.560.37
0.960.910.960.790.750.680.610.510.970.960.930.920.97-0.030.820.650.920.90.680.040.88-0.50.130.930.790.82
0.590.350.620.660.630.020.660.510.550.640.490.480.610.470.510.690.470.450.670.240.71-0.130.40.520.520.4
1.00.920.990.810.770.70.550.970.550.980.980.980.990.040.780.610.980.970.66-0.110.89-0.470.080.990.840.89
0.990.870.990.830.790.610.650.960.640.980.950.940.990.150.810.710.940.920.74-0.010.92-0.430.190.960.820.84
0.980.950.960.770.710.760.410.930.490.980.951.00.97-0.020.740.491.00.990.55-0.250.83-0.47-0.061.00.830.92
0.970.960.960.770.70.780.390.920.480.980.941.00.96-0.040.740.471.00.990.53-0.240.81-0.49-0.090.990.830.92
1.00.91.00.860.80.660.60.970.610.990.990.970.960.110.820.660.960.940.7-0.020.92-0.50.140.980.840.86
0.11-0.310.150.310.32-0.490.55-0.030.470.040.15-0.02-0.040.110.160.5-0.05-0.070.490.230.320.020.730.040.08-0.05
0.80.70.810.710.780.480.70.820.510.780.810.740.740.820.160.770.730.720.770.20.74-0.450.190.730.840.81
0.640.360.690.730.850.050.970.650.690.610.710.490.470.660.50.770.460.420.980.460.82-0.270.690.540.70.52
0.970.960.950.740.670.790.370.920.470.980.941.01.00.96-0.050.730.461.00.51-0.260.8-0.45-0.110.990.820.92
0.960.950.940.690.630.80.330.90.450.970.920.990.990.94-0.070.720.421.00.47-0.30.76-0.42-0.160.980.80.92
0.690.410.730.790.910.110.950.680.670.660.740.550.530.70.490.770.980.510.470.40.87-0.340.70.60.760.58
-0.08-0.2-0.030.250.18-0.240.580.040.24-0.11-0.01-0.25-0.24-0.020.230.20.46-0.26-0.30.40.18-0.130.57-0.23-0.11-0.3
0.910.710.930.940.910.40.790.880.710.890.920.830.810.920.320.740.820.80.760.870.18-0.490.480.870.790.71
-0.48-0.5-0.47-0.63-0.5-0.53-0.26-0.5-0.13-0.47-0.43-0.47-0.49-0.50.02-0.45-0.27-0.45-0.42-0.34-0.13-0.49-0.11-0.48-0.45-0.42
0.12-0.250.180.440.5-0.490.780.130.40.080.19-0.06-0.090.140.730.190.69-0.11-0.160.70.570.48-0.110.030.12-0.12
0.990.920.970.810.760.720.460.930.520.990.961.00.990.980.040.730.540.990.980.6-0.230.87-0.480.030.840.91
0.840.760.840.760.890.560.560.790.520.840.820.830.830.840.080.840.70.820.80.76-0.110.79-0.450.120.840.95
0.880.870.860.670.740.730.370.820.40.890.840.920.920.86-0.050.810.520.920.920.58-0.30.71-0.42-0.120.910.95
Click cells to compare fundamentals
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Competition

Globus Common Stock Shares Outstanding

Common Stock Shares Outstanding

104.12 Million

At present, Globus Medical's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting.
In accordance with the recently published financial statements, the book value per share of Globus Medical is about 29.324 times. This is 1824.94% lower than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The book value per share for all United States stocks is 98.48% higher than that of the company.

Globus Book Value Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Globus Medical's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Globus Medical could also be used in its relative valuation, which is a method of valuing Globus Medical by comparing valuation metrics of similar companies.
Globus Medical is currently under evaluation in book value per share category among related companies.

Globus Fundamentals

About Globus Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Globus Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Globus Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Globus Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Globus Medical Piotroski F Score and Globus Medical Altman Z Score analysis.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Earnings Share
1.07
Revenue Per Share
13.87
Quarterly Revenue Growth
1.246
Return On Assets
0.0477
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.